Anondita Medicare IPO: Price, GMP, Analysis, And Details

Anondita Medicare IPO- Company Analysis

Anondita Medicare IPO under the SME IPO category is a bookbuilding issue of Rs. 69.50 Cr by Anondita Medicare Ltd, which was incorporated in 2024 and produces flavored male condoms under the "COBRA" brand.

Every year, the company makes 562 million condoms.

It collaborates with governments, non-governmental organizations, and international health organizations to support family planning and public health initiatives. 

The company collaborates with e-commerce platforms, wholesalers, and retailers to make its products widely accessible.

It also keeps up strong ties with government health initiatives and groups, which greatly aid in the supply of essential medical equipment for public health campaigns.

Our new brand has been thoroughly tested electronically, features eye-catching graphics and images, and comes in a variety of flavors, including strawberry, mint, chocolate, butterscotch, coffee, and bubblegum.

 

Anondita Medicare IPO Details

The Anondita Medicare IPO date is on 22 August 2025, and its initial public offering will end on 26 Aug with IPO allotment on Aug 28, and refund initiation on Aug 29, 2025.

The Rs. 69.50 crore new SME IPO comprises a fresh issue of 0.48 crore Shares.

The Anondita Medicare IPO listing date (expected) might be on Monday, Sep 01, 2025, and listing at the NSE and SME. 

The Anondita Medicare IPO price band is Rs. 137 to Rs. 145.

IPO Timetable (Tentative)

Events	Date
IPO Opening Date	Aug 22, 2025
IPO Closing Date	Aug 26, 2025
IPO Allotment Date	Aug 28, 2025
Refund Initiation	Aug 29, 2025
IPO Listing Date	Sep 01, 2025

 

Click to open demat account and apply for the IPO.

Company Financials

(Amount in Cr)

Period	31 Mar 2025	31 Mar 2024	31 Mar 2023
Total Assets	78.27	42.92	37.80
Total Revenue	77.13	46.56	36.14
PAT	16.42	3.84	0.35
EBITDA	25.65	9.09	3.58
Net Worth	37.87	10.59	8.69
Reserves & Surplus	24.58	10.39	6.55
Borrowings	27.39	24.01	22.66

 

 

Cash Flows

(Amount in lac)

Net Cash Flow in Multiple Activities	31 Mar 2025	31 Mar 2024	31 Mar 2023
Net Cash Flow Operating Activities	607.96	(7)	(949.63)
Net Cash Flow Investing Activities	(2292.89)	-	(25.34)
Net Cash Flow Financing Activities	1707.49	10	990.72

 

Revenue Bifurcation

The Objective of the Issue

The company desires to use the Net Proceeds from the Issue to fulfill its following goals:

• Financing the necessary capital expenditures for the acquisition of machinery and equipment. ~ Rs. 60 Cr.

• Meeting the working capital requirement. ~Rs. 350 Cr. 

• Unknown purchase general corporate purposes.
  
  

Listed Peers of Anondita Medicare Ltd. 

Company Name	Face Value (Rs. per Share)	EPS (Rs.)	P/E (x)
Cupid Limited	1	1.52	110.38

 

Valuation

Metric	Value
ROE	41.71%
ROCE	37.42%
RoNW	41.71%
PAT Margin	21.32%
Price to Book Value	15.07
EBITDA Margin	33.32%
Debt/Equity	0.70

 

Evaluation of P/E Ratio

Considering the FY ended on 31 Mar 2025 with an EPS of Rs. 9.60 from the last year, the resulting P/E ratio is 15.10x. When compared with the industry’s average P/E of 110.38x, it indicates an undervaluation (on a P/E ratio basis only). Hence, the price of the Share seems fairly priced for the investors.

Explore the Studio LSD IPO.

 

IPO's Strengths 

• Seasoned and important condom producer in India.

• Acknowledged in North India.

• Provides a wide variety of goods.

 

 

IPO’s Weaknesses 

• The price volatility of latex raw materials has been recognized as the main threat.

• The need for cleaner alternatives for the production of contraceptives is growing as the threat posed by climate change intensifies.

• The primary flaw is the reliance on the supply chain to get raw materials for latex.
  
  

Anondita Medicare IPO GMP (Grey Market Premium)

Anondita Medicare IPO GMP today is Rs. 0 as of 19 Aug 2025 at the time of writing this information.

Anondita Medicare IPO Summary

The Anondita Medicare IPO has a market maker portion size of 2,70,000 Shares (Rs. 3.92 Cr).

IPO Opening & Closing Date	22 Aug, 2025 to 26 Aug, 2025
Face Value	Rs. 10 per Share
Issue Price	Rs. 137 to Rs. 145 per Share.
Lot Size	1000 Shares
Issue Size	47,93,000 Shares (Rs. 69.50 Cr)
Offer for Sale	-
Fresh Issue	47,93,000 Shares (Rs. 69.50 Cr)
Listing at	NSE, SME
Issue Type	Bookbuilding IPO
Registrar	Maashitla Securities Pvt. Ltd.

 

 

IPO Lot Details 

Retail investors can invest in a minimum and maximum of 2 Lots (2000 Shares) for Rs. 2,90,000 and in multiples thereof, while for S-HNI investors, the minimum Lot is 3 (3000 Shares) for Rs. 4,35,000.

Minimum Lot Investment (Retail)	2 Lots
Maximum Lot Investment (Retail)	2 Lots
S-HNI (Min)	3 Lots

 

Anondita Medicare IPO Allotment Status

To check the Anondita Medicare IPO Allotment Status, visit the official Registrar’s website or the BSE website. Below are the website links for you.

Using BSE Website - ​BSE IPO allotment status

 

Promoters And Management of Anondita Medicare Ltd.

• Mr. Anupam Ghosh

• Mrs. Sonia Ghosh

• Mr. Reshant Ghosh.

Pre-Issue Promoter Shareholding	83.95%
Post-Issue Promoter Shareholding	61.71%

 

IPO Lead Managers

• Narnolia Financial Services Ltd. 

 

 

Dividend Policy

The company has not paid a dividend in any year.

 

Conclusion

Investors can gain exposure to one of India's well-known condom makers with robust financial growth and a solid EBITDA margin of 33.32% through the Anondita Medicare IPO. The business has bright futures thanks to strong demand, government partnerships, and development ambitions. However, market risks and reliance on raw materials should be properly taken into account.

 

Finowings IPO Analysis

Hope you enjoyed the Finowings IPO Analysis. We tried our best to give every required detail about the company that you should know before applying to the IPO. 

You must consult your financial advisor before making any financial decisions. 

To Apply for the IPO, Click Here.

To Read the Prospectus of the Company Click Here to Download the DRHP.

Click Here To Stay Updated With The Upcoming IPOs.

DISCLAIMER: This blog is NOT any buy or sell recommendation. No investment or trading advice is given. The content is purely for educational and information purposes only. Always consult your eligible financial advisor for investment-related decisions.